149 related articles for article (PubMed ID: 32187278)
1. Apoptosis-related gene expression can predict the response of ovarian cancer cell lines to treatment with recombinant human TRAIL alone or combined with cisplatin.
Braga LDC; Gonçales NG; Furtado RS; Andrade WP; Silva LM; Silva Filho ALD
Clinics (Sao Paulo); 2020; 75():e1492. PubMed ID: 32187278
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.
Duiker EW; Meijer A; van der Bilt AR; Meersma GJ; Kooi N; van der Zee AG; de Vries EG; de Jong S
Br J Cancer; 2011 Apr; 104(8):1278-87. PubMed ID: 21487429
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model.
Duiker EW; de Vries EG; Mahalingam D; Meersma GJ; Boersma-van Ek W; Hollema H; Lub-de Hooge MN; van Dam GM; Cool RH; Quax WJ; Samali A; van der Zee AG; de Jong S
Clin Cancer Res; 2009 Mar; 15(6):2048-57. PubMed ID: 19276284
[TBL] [Abstract][Full Text] [Related]
4. [Effects of recombinant human tumor-necrosis factor related to apoptosis inducing ligand protein on apoptosis of human lung adenocarcinoma cell line resistant to cisplatin].
Zhang M; Hu C; Chen Q; Yang H
Zhongguo Fei Ai Za Zhi; 2005 Oct; 8(5):419-23. PubMed ID: 21205524
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines.
Van Geelen CM; Pennarun B; Ek WB; Le PT; Spierings DC; De Vries EG; De Jong S
Int J Oncol; 2010 Oct; 37(4):1031-41. PubMed ID: 20811726
[TBL] [Abstract][Full Text] [Related]
6. Antrodia camphorata induces apoptosis and enhances the cytotoxic effect of paclitaxel in human ovarian cancer cells.
Liu FS; Yang PY; Hu DN; Huang YW; Chen MJ
Int J Gynecol Cancer; 2011 Oct; 21(7):1172-9. PubMed ID: 21897275
[TBL] [Abstract][Full Text] [Related]
7. Valproic Acid as a Promising Co-Treatment With Paclitaxel and Doxorubicin in Different Ovarian Carcinoma Cell Lines.
Kwiecińska P; Taubøll E; Grzyb E; Fiedor E; Ptak A; Gregoraszczuk EL
Int J Gynecol Cancer; 2016 Nov; 26(9):1546-1556. PubMed ID: 27654264
[TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation.
de Lima AB; Silva LM; Gonçales NG; Carvalho MRS; da Silva Filho AL; da Conceição Braga L
Cancer Microenviron; 2018 Jun; 11(1):85-92. PubMed ID: 29307001
[TBL] [Abstract][Full Text] [Related]
9. MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin.
Bieg D; Sypniewski D; Nowak E; Bednarek I
Arch Gynecol Obstet; 2019 Apr; 299(4):1077-1087. PubMed ID: 30585294
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway.
Zhang C; Wang M; Shi C; Shi F; Pei C
Biosci Trends; 2018 Jul; 12(3):309-316. PubMed ID: 29952351
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines.
Smith JA; Ngo H; Martin MC; Wolf JK
Gynecol Oncol; 2005 Jul; 98(1):141-5. PubMed ID: 15963813
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.
Samouëlian V; Maugard CM; Jolicoeur M; Bertrand R; Arcand SL; Tonin PN; Provencher DM; Mes-Masson AM
Cancer Chemother Pharmacol; 2004 Dec; 54(6):497-504. PubMed ID: 15258697
[TBL] [Abstract][Full Text] [Related]
13. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
[TBL] [Abstract][Full Text] [Related]
14. Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells.
Wang H; Zhang Z; Wei X; Dai R
J Ovarian Res; 2015 Feb; 8():3. PubMed ID: 25823945
[TBL] [Abstract][Full Text] [Related]
15. Intervention effects of nedaplatin and cisplatin on proliferation and apoptosis of human tumour cells in vitro.
Su XY; Yin HT; Li SY; Huang XE; Tan HY; Dai HY; Shi FF
Asian Pac J Cancer Prev; 2012; 13(9):4531-6. PubMed ID: 23167374
[TBL] [Abstract][Full Text] [Related]
16. Oleuropein reduces cisplatin resistance in ovarian cancer by targeting apoptotic pathway regulators.
Hashemi Sheikhshabani S; Amini-Farsani Z; Rahmati S; Jazaeri A; Mohammadi-Samani M; Asgharzade S
Life Sci; 2021 Aug; 278():119525. PubMed ID: 33894272
[TBL] [Abstract][Full Text] [Related]
17. Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL.
Meijer A; Kruyt FA; van der Zee AG; Hollema H; Le P; ten Hoor KA; Groothuis GM; Quax WJ; de Vries EG; de Jong S
Br J Cancer; 2013 Nov; 109(10):2685-95. PubMed ID: 24136147
[TBL] [Abstract][Full Text] [Related]
18. Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids.
L'Espérance S; Bachvarova M; Tetu B; Mes-Masson AM; Bachvarov D
BMC Genomics; 2008 Feb; 9():99. PubMed ID: 18302766
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B X-interacting protein promotes cisplatin resistance and regulates CD147 via Sp1 in ovarian cancer.
Zou W; Ma X; Yang H; Hua W; Chen B; Cai G
Exp Biol Med (Maywood); 2017 Mar; 242(5):497-504. PubMed ID: 28056551
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]